Omnia Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Buy
3,907
+428
+12% +$24.6K 0.06% 90
2026
Q1
$211K Buy
+3,479
New +$203K 0.07% 85
2019
Q2
Sell
-390
Closed -$19K 152
2019
Q1
$19K Sell
390
-379
-49% -$18.9K 0.01% 215
2018
Q4
$40K Hold
769
0.02% 162
2018
Q3
$48K Hold
769
0.02% 156
2018
Q2
$43K Sell
769
-94
-11% -$5.08K 0.02% 160
2018
Q1
$55K Sell
863
-50
-5% -$3.22K 0.03% 146
2017
Q4
$56K Buy
913
+231
+34% +$14.4K 0.03% 151
2017
Q3
$43K Sell
682
-198
-23% -$11.6K 0.02% 157
2017
Q2
$49K Sell
880
-174
-17% -$9.47K 0.02% 152
2017
Q1
$57K Buy
1,054
+218
+26% +$12K 0.03% 149
2016
Q4
$49K Buy
+836
New +$45.7K 0.02% 160

Other funds holding BMY

Omnia Family Wealth's BMY Position: Q2 2026 in Review

Omnia Family Wealth increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $24.6K and bringing the position to 3,907 shares worth $225K. The position accounts for 0.06% of the portfolio, ranked #90.

Omnia Family Wealth first reported a position in BMY in Q4 2016 and has held it in 12 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Omnia Family Wealth held 3,907 shares of Bristol-Myers Squibb worth $225K as of Q2 2026.
  • Omnia Family Wealth bought 428 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.6K.
  • Bristol-Myers Squibb made up 0.06% of Omnia Family Wealth's portfolio in Q2 2026, its #90 holding.
  • Omnia Family Wealth first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 12 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Omnia Family Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.